
Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
Author(s) -
Patricia Udaondo,
Ana Hervás-Ontiveros,
Amir Rosemblatt,
S. García-Delpech
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s336865
Subject(s) - medicine , dexamethasone , ophthalmology , intraocular pressure , macular edema , visual acuity , implant , odds ratio , diabetic macular edema , diabetic retinopathy , surgery , diabetes mellitus , endocrinology
To determine the impact of different baseline clinical characteristics on the improvement in best corrected visual acuity (BCVA) in patients with diabetic macular edema (DME) who underwent the intravitreal dexamethasone implant (DEX) Ozurdex ® .